Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Category: Health Industry
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
FDA To End Program That Hid Millions Of Reports On Faulty Medical Devices
In the wake of a KHN investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.
Even Doctors Can’t Navigate Our ‘Broken Health Care System’
A physician’s frustration navigating a medical emergency with his elderly father reveals a complex, dysfunctional system.
Will Ties To A Catholic Hospital System Tie Doctors’ Hands?
Doctors at the University of California’s flagship San Francisco hospital are sharply divided over a proposal to join forces with a Catholic-run system that restricts care on the basis of religious doctrine — part of a broader public debate as Catholic hospitals expand their reach.
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Newsom: California Leads On Prescription Drugs
California regularly portrays itself as a national trendsetter on political issues, and Gov. Gavin Newsom is claiming that title on prescription drugs. Newsom has a plan to take on the drug industry, and at an April 17 news conference in Southern California, he declared that two other governors already want to join his effort. […]
Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High
It’s as shady as it sounds.
Patients Caught In Middle Of Fight Between Health Care Behemoths
A legal battle in Pennsylvania is testing the boundaries of health care competition and government action to oversee and regulate it.
